Home › NDC Lookup › Ingredients › Calcium Carbonate › 00121-0766-16
Calcium Carbonate 1250 mg/5mL Suspension — NDC 00121-0766-16 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Calcium Carbonate 1250 mg/5mL Suspension — NDC 0121-0766-16 (Billing 00121-0766-16)

by PAI Holdings, LLC dba PAI Pharma · 12 BOTTLE in 1 CASE / 473 mL in 1 BOTTLE

This is a package of Calcium Carbonate 1250 mg/5mL Suspension from PAI Holdings, LLC dba PAI Pharma, marketed since Dec 2004 and currently FDA-listed; retail pharmacies pay about $0.0204 per mL (NADAC). It is this product's only package size.

NDC 00121-0766-16
🏷️ FDA NDC (as labeled) 0121-0766-16 billing pads the labeler segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 0121-0766-16 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0121 labeler · 0766 product · 16 package
Package marketed since
Dec 1, 2004
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 0121076616 9
Medicaid fills, this package
26,494 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Calcium Carbonate (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · May 28, 2026 — Presence of foreign substance: small metallic particles in chewable tablets. (Guardian Drug Co. Inc.) · FDA recall D-0573-2026
Class II · May 28, 2026 — Presence of foreign substance: small metallic particles in chewable tablets. (Guardian Drug Co. Inc.) · FDA recall D-0561-2026
Class II · May 28, 2026 — Presence of foreign substance: small metallic particles in chewable tablets. (Guardian Drug Co. Inc.) · FDA recall D-0578-2026
Class II · May 28, 2026 — Presence of foreign substance: small metallic particles in chewable tablets. (Guardian Drug Co. Inc.) · FDA recall D-0568-2026
Class II · May 28, 2026 — Presence of foreign substance: small metallic particles in chewable tablets. (Guardian Drug Co. Inc.) · FDA recall D-0579-2026
Class II · May 28, 2026 — Presence of foreign substance: small metallic particles in chewable tablets. (Guardian Drug Co. Inc.) · FDA recall D-0560-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0121-0766-16
Product NDC 0121-0766
11-digit billing NDC 00121076616
NCPDP billing unit ML — per mL (volume)
RxCUI 308891
UNII H0G9379FGK
Application # M001
SPL Set ID d89f3184-7081-4e16-a504-9214283891f6
Established class (EPC) Blood Coagulation Factor; Cations; Phosphate Binder
Mechanism of action Phosphate Chelating Activity
Physiologic effect Increased Coagulation Factor Activity
Chemical class Calcium; Divalent
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2004-12-01
Route ORAL
Dosage form SUSPENSION
Substance CALCIUM CARBONATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 48300010001815
GPI class Calcium Carbonate Antacid
GCN Seq No 002684
GCN 07872
HICL code 000581
Ingredient (HICL) Calcium Carbonate
HIC1 code C
Therapeutic class — broad (HIC1) Electrolyte Balance/Metabolism/Nutrition
HIC2 code C1
Therapeutic class — intermediate (HIC2) Drugs Affecting Electrolyte Balance
HIC3 code C1F
Therapeutic class — specific (HIC3) Calcium Replacement
AHFS code 40:12.00.00
AHFS class Replacement Preparations
FDB label name CALCIUM CARB 1,250 MG/5 ML SUS
FDB brand name Calcium Carbonate
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 002684
  • GCN: 07872
  • GPI-14 (Medi-Span): 48300010001815
  • HICL (First Databank): 000581
  • AHFS class code: 40:12.00.00
  • RxCUI (RxNorm): 308891
Why two NDCs? The FDA registers this code as 0121-0766-16 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00121-0766-16. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Calcium compounds class.

Drug family (ATC) Calcium compounds, Calcium
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name CALCIUM CARB 1,250 MG/5 ML SUS Ingredient Calcium Carbonate
📖 What it is MedlinePlus · NLM

Calcium carbonate is a dietary supplement used when the amount of calcium taken in the diet is not enough. Calcium is needed by the body for healthy bones, muscles, nervous system, and heart. Calcium carbonate also is used as an antacid to relieve heartburn, acid indigestion, and upset stomach. It is available with or without a prescription. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Most often it's an antacid. It relieves heartburn, acid indigestion, sour stomach and upset stomach tied to those symptoms. A few supplement products have other uses, like bone sup...
  • What is calcium carbonate usually used for?
  • You chew it when symptoms come on. Many labels say to chew or crush the tablets completely and not swallow them whole. The number of tablets varies by product, so read your label o...
  • Many labels say not to use the maximum dose for more than 2 weeks unless a doctor is supervising you. If your symptoms last longer than 2 weeks, check in with your doctor.
📖 Read our full Calcium Carbonate guide →
4
Nutrient depletion considerations

Calcium Carbonate may be associated with lower levels of 4 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Calcium Carbonate nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.020 $115.79 / 5676 ml
Medicaid paysCMS SDUD · 12 mo $0.0376 $213.42 / 5676 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Sep 2021 Dec 2023 Mar 2026 Sep 2026 $0.021 $0.015
▲ Up 35% over the last 19 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00121-0766-16 You're viewing this Main listing 12 BOTTLE in 1 CASE / 473 mL in 1 BOTTLE 2004-12-01 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Calcium Carbonate 1250 mg/5mLthis 00121-0766-16 PAI 12 bottles $0.020 — Availability likely —
Calcium Carbonate 1250 mg/5mL 00121-4766-05 PAI 10 cups — — FDA listed —
Calcium Carbonate 1250 mg/5mL 17856-3117-03 Atlantic 5 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2004
On the market since
Dec 2004
📍
2026
Currently FDA-listed
22 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color pink
FlavorBubble Gum
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Calcium Carbonate inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII XF417D3PSL
    Anhydrous citric acid is a sour, crystalline powder derived from citric acid with water removed. In medicines, it acts as a buffer to control pH, adds tartness to improve taste, and helps tablets disintegrate.
  • UNII 9DBA0SBB0L
    A synthetic red dye derived from coal tar used as a colorant in medicines and cosmetics. It gives tablets, capsules, and liquids their red or pink appearance for identification and visual appeal.
  • UNII WZB9127XOA
    A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII A2I8C7HI9T
    Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII Z8IX2SC1OH
    Propylparaben is a chemical preservative used to prevent bacterial and fungal growth in medicines and personal care products. It helps extend shelf life and maintain product safety during storage.
  • UNII 5101OP7P2I
    Saccharin calcium is an artificial sweetener made from saccharin combined with calcium. It's used in medicines to make tablets or liquids taste better so they're easier to take.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII TTV12P4NEE
    Xanthan gum is a thickening and stabilizing ingredient made from fermented corn or other sugars. It's added to medicines to improve texture, prevent separation of liquids and solids, and help the product stay consistent.

11 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescalcium saccharin, citric acid, D&C Red No. 33, FD&C Red No. 40, flavoring, glycerin, methylparaben, propylene glycol, propylparaben, purified water, sorbitol and xanthan gum.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPAI Holdings, LLC dba PAI Pharma
FDA applicationM001 (OTC MONOGRAPH DRUG)
Labeler code00121
First marketedDec 2004
Product typeHuman Otc Drug
Portfolio142 products on file

More NDCs from PAI Holdings, LLC dba PAI Pharma labeler code 00121

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor or Pharmacist Before Use If 📄 When Using This Product 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 13 words ▾

Uses Relieves: heartburn acid indigestion sour stomach upset stomach associated with these symptoms

⏱️ Dosage and Administration 23 words ▾

Directions Shake well before using. Take 1 to 2 teaspoonfuls (5 to 10 mL) as symptoms occur, or as directed by a doctor.

⚠️ Warnings 55 words ▾

Warnings Ask a doctor or pharmacist before use if you are taking a prescription drug. Antacids may interact with certain prescription drugs. When using this product, do not take more than 6 teaspoonfuls (30 mL) in a 24-hour period or use the maximum dosage for more than 2 weeks. Keep out of reach of children.

📦 Storage and Handling 52 words ▾

Other information store at 20° - 25°C (68° - 77°F) do not freeze Calcium Carbonate Oral Suspension is a pink-colored, bubble gum flavored suspension supplied in the following oral dosage forms: NDC 0121-0766-16: 16 fl oz (473 mL) bottle NDC 0121-4766-05: 5 mL unit dose cup, in a tray of ten cups.

🧪 Active Ingredient 17 words ▾

Active ingredient (in each 5 mL teaspoonful) Calcium Carbonate 1250 mg (Equivalent to 500 mg elemental Calcium)

🧪 Inactive Ingredients 26 words ▾

Inactive ingredients calcium saccharin, citric acid, D&C Red No. 33, FD&C Red No. 40, flavoring, glycerin, methylparaben, propylene glycol, propylparaben, purified water, sorbitol and xanthan gum.

🎯 Purpose 2 words ▾

Purpose Antacid

📄 Ask a Doctor or Pharmacist Before Use If 21 words ▾

Ask a doctor or pharmacist before use if you are taking a prescription drug. Antacids may interact with certain prescription drugs.

📄 When Using This Product 27 words ▾

When using this product, do not take more than 6 teaspoonfuls (30 mL) in a 24-hour period or use the maximum dosage for more than 2 weeks.

📄 Keep Out of Reach of Children 6 words ▾

Keep out of reach of children.

📄 Questions or Comments 16 words ▾

Questions or comments? Call 1-800-845-8210. You may also report serious side effects to this phone number.

📄 Package Label / Principal Display Panel 106 words ▾

PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label NDC 0121-0766-16 Quality ® Value Calcium Carbonate Oral Suspension 1250 mg/5 mL Maximum Strength ANTACID Daily source of calcium SUGAR FREE / ALCOHOL FREE SODIUM FREE 16 fl oz (473 mL) Pharmaceutical Associates, Inc. Greenville, SC 29605 Principal Display Panel - 473 mL Bottle Label

PRINCIPAL DISPLAY PANEL - 5 mL Cup Tray Label Delivers 5 mL NDC 0121-4766-05 Calcium Carbonate Oral Suspension 1250 mg/5 mL (equivalent to 500 mg of elemental Calcium) ANTACID – SHAKE WELL Package Not Child-Reistant Pharmaceutical Associates, Inc. Greenville, SC 29605 SEE INSERT A0766051021 PRINCIPAL DISPLAY PANEL - 5 mL Cup Tray Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
26.5K
Units reimbursed last 4 qtrs
6.9M
Gross reimbursed last 4 qtrs
$260.7K
Avg / prescription
$9.84
Avg / unit
$0.0376
Latest quarter Q1 2026
6.2KRx
Medicaid pays / mL
$0.0376
gross reimbursed
vs
NADAC / mL
$0.0204
acquisition cost
=
Spread
+$0.0172
+84% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
50% FFS 50% MCO
Fee-for-service · 13,237 Rx Managed care · 13,257 Rx
State Medicaid map
Alaska: no data reported AK Maine: 38,775 units · 2,780 per 100k residents ME Washington: 136,276 units · 1,744 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 588,695 units · 10,261 per 100k residents MN Wisconsin: 195,164 units · 3,302 per 100k residents WI Michigan: 226,766 units · 2,259 per 100k residents MI New York: 853,613 units · 4,362 per 100k residents NY Vermont: 19,626 units · 3,033 per 100k residents VT New Hampshire: no data reported NH Oregon: 92,403 units · 2,183 per 100k residents OR Nevada: 86,755 units · 2,716 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 29,490 units · 920 per 100k residents IA Illinois: 198,266 units · 1,580 per 100k residents IL Indiana: 281,105 units · 4,097 per 100k residents IN Ohio: 552,988 units · 4,692 per 100k residents OH Pennsylvania: 813,985 units · 6,280 per 100k residents PA New Jersey: 227,822 units · 2,452 per 100k residents NJ Massachusetts: 404,547 units · 5,778 per 100k residents MA California: no data reported CA Utah: 40,605 units · 1,188 per 100k residents UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: 139,048 units · 2,244 per 100k residents MO Kentucky: 254,189 units · 5,616 per 100k residents KY West Virginia: no data reported WV Virginia: 200,614 units · 2,302 per 100k residents VA Maryland: 30,677 units · 496 per 100k residents MD Connecticut: 70,394 units · 1,946 per 100k residents CT Rhode Island: 8,612 units · 786 per 100k residents RI Arizona: 161,074 units · 2,168 per 100k residents AZ New Mexico: 67,139 units · 3,176 per 100k residents NM Kansas: no data reported KS Arkansas: 53,121 units · 1,732 per 100k residents AR Tennessee: 94,975 units · 1,333 per 100k residents TN North Carolina: no data reported NC South Carolina: 106,555 units · 1,983 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: 90,080 units · 1,969 per 100k residents LA Mississippi: 74,062 units · 2,519 per 100k residents MS Alabama: no data reported AL Georgia: 15,292 units · 139 per 100k residents GA D.C.: 78,386 units · 11,544 per 100k residents DC Hawaii: 36,351 units · 2,533 per 100k residents HI Texas: 673,541 units · 2,208 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
13911,544
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 D.C. 11,544 /100k
2 Minnesota 10,261 /100k
3 Pennsylvania 6,280 /100k
4 Massachusetts 5,778 /100k
5 Kentucky 5,616 /100k
6 Ohio 4,692 /100k
7 New York 4,362 /100k
8 Indiana 4,097 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Calcium Carbonate — the ingredient across all brands.

Top reported reactions

Fatigue6,942
Nausea6,462
Diarrhoea5,709
Chronic Kidney Disease5,699
Pain5,439
Dyspnoea5,193
Vomiting5,013

Age at onset

Neonate89
Infant35
Child177
Adolescent182
Adult5,184
Elderly5,139

Reporter sex

73,758 reports
Male · 33%
Female · 67%
Unknown · 0%

Serious outcomes

Hospitalization29,678
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 5,794 2,403
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 00121-0759-08 · PAI 00121-0770-01 · Pharmaceutical →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.